Variant report

Variant	nsv570
Chromosome Location	chr12:366791-395823
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:186)
CpG islands
(count:613)
Chromatin interactive
region (count:14)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:186 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr12:373538-373815	K562	blood:	n/a	n/a
2	BATF	chr12:382502-382775	GM12878	blood:	n/a	n/a
3	BCL11A	chr12:368058-368307	GM12878	blood:	n/a	n/a
4	BCL3	chr12:377133-378098	A549	lung:	n/a	n/a
5	BRCA1	chr12:388853-388959	Hela-S3	cervix:	n/a	n/a
6	CEBPB	chr12:373496-373744	K562	blood:	n/a	n/a
7	CTCF	chr12:376720-376870	SAEC	small airway:	n/a	n/a
8	CTCF	chr12:391149-391201	Lung_OC	lung:	n/a	n/a
9	CTCF	chr12:391102-391136	Spleen_OC	spleen:	n/a	n/a
10	CTCF	chr12:382320-382470	HCPEpiC	choroid plexus:	n/a	n/a
11	CUX1	chr12:373538-373615	K562	blood:	n/a	n/a
12	E2F4	chr12:392202-392344	MCF10A-Er-Src	breast:	n/a	n/a
13	EP300	chr12:373428-374103	K562	blood:	n/a	n/a
14	ESR1	chr12:372002-372346	ECC-1	luminal epithelium:	n/a	n/a
15	FAM48A	chr12:393132-393260	GM12878	blood:	n/a	n/a
16	FOS	chr12:372922-373109	MCF10A-Er-Src	breast:	n/a	chr12:372990-373000
17	FOXA1	chr12:383279-383584	T-47D	breast:	n/a	chr12:383516-383528
18	FOXA1	chr12:382698-383077	T-47D	breast:	n/a	chr12:382894-382909 chr12:382860-382875
19	FOXA1	chr12:387844-388107	HepG2	liver:	n/a	n/a
20	FOXA1	chr12:382677-382977	T-47D	breast:	n/a	chr12:382894-382909 chr12:382860-382875
21	GATA1	chr12:373339-373784	PBDE	blood:	n/a	n/a
22	GATA1	chr12:373161-373880	K562	blood:	n/a	n/a
23	GATA2	chr12:373545-373749	SH-SY5Y	brain:	n/a	n/a
24	GATA2	chr12:367995-368216	SH-SY5Y	brain:	n/a	n/a
25	GATA3	chr12:368292-368701	SH-SY5Y	brain:	n/a	n/a
26	HNF4A	chr12:380373-380573	HepG2	liver:	n/a	chr12:380519-380534 chr12:380520-380534 chr12:380519-380534 chr12:380518-380536 chr12:380519-380534 chr12:380521-380533 chr12:380520-380533 chr12:380519-380534 chr12:380519-380534 chr12:380521-380533
27	IRF1	chr12:373834-373835	K562	blood:	n/a	n/a
28	JUND	chr12:372048-372141	K562	blood:	n/a	n/a
29	JUND	chr12:376215-376332	HepG2	liver:	n/a	n/a
30	JUND	chr12:372969-373030	K562	blood:	n/a	chr12:372990-373000
31	JUND	chr12:373451-373805	K562	blood:	n/a	n/a
32	MAFF	chr12:373589-373727	K562	blood:	n/a	n/a
33	MAFK	chr12:373506-373800	K562	blood:	n/a	n/a
34	MAFK	chr12:382695-382869	HepG2	liver:	n/a	n/a
35	MAFK	chr12:390449-390555	H1-hESC	embryonic stem cell:	n/a	n/a
36	MAFK	chr12:373576-373776	HepG2	liver:	n/a	n/a
37	MAX	chr12:367088-367381	HepG2	liver:	n/a	chr12:367250-367257 chr12:367163-367173 chr12:367248-367258 chr12:367249-367258
38	MAX	chr12:373552-373712	K562	blood:	n/a	n/a
39	MAX	chr12:367008-367501	HepG2	liver:	n/a	chr12:367250-367257 chr12:367163-367173 chr12:367248-367258 chr12:367249-367258
40	MAX	chr12:371771-372518	ECC-1	luminal epithelium:	n/a	n/a
41	MAX	chr12:371780-372537	ECC-1	luminal epithelium:	n/a	n/a
42	MAZ	chr12:372035-372250	K562	blood:	n/a	n/a
43	MAZ	chr12:373629-373715	K562	blood:	n/a	n/a
44	MYC	chr12:367190-367192	HepG2	liver:	n/a	n/a
45	MYC	chr12:373496-373738	K562	blood:	n/a	n/a
46	MYC	chr12:372082-372218	K562	blood:	n/a	n/a
47	MYC	chr12:367226-367280	HepG2	liver:	n/a	chr12:367250-367257 chr12:367248-367258 chr12:367249-367258
48	POLR2A	chr12:378592-378655	HUVEC	blood vessel:	n/a	n/a
49	POLR2A	chr12:386994-387404	GM12892	blood:	n/a	n/a
50	POLR2A	chr12:374781-374783	HepG2	liver:	n/a	n/a

(count:613 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:378771-378821	PrEC	prostate:	n/a
2	chr12:372246-372296	ovcar-3	ovarian:	n/a
3	chr12:371916-371966	H1-hESC	embryonic stem cell:	embryo
4	chr12:378771-378821	PrEC	prostate:	n/a
5	chr12:372246-372296	ovcar-3	ovarian:	n/a
6	chr12:371916-371966	H1-hESC	embryonic stem cell:	embryo
7	chr12:372790-372840	HRPEpiC	eye:	n/a
8	chr12:371950-372000	HRPEpiC	eye:	n/a
9	chr12:371916-371966	ovcar-3	ovarian:	n/a
10	chr12:372049-372099	GM06990	blood:	n/a
11	chr12:378771-378821	PANC-1	pancreas:	n/a
12	chr12:372246-372296	LNCaP	prostate:	n/a
13	chr12:372049-372099	NT2-D1	testis:	n/a
14	chr12:378771-378821	ProgFib	skin:	n/a
15	chr12:372790-372840	GM12891	blood:	n/a
16	chr12:371916-371966	PrEC	prostate:	n/a
17	chr12:372191-372241	NH-A	brain:	n/a
18	chr12:372259-372309	U87	brain:	n/a
19	chr12:372246-372296	GM06990	blood:	n/a
20	chr12:372191-372241	HRE	kidney:	n/a
21	chr12:392537-392587	AoSMC	blood vessel:	n/a
22	chr12:372049-372099	SK-N-SH	brain:	n/a
23	chr12:372790-372840	U87	brain:	n/a
24	chr12:378771-378821	SKMC	muscle:	n/a
25	chr12:372191-372241	CMK	blood:	n/a
26	chr12:371916-371966	U87	brain:	n/a
27	chr12:392537-392587	A549	lung:	n/a
28	chr12:371916-371966	Hepatocyte	liver:	n/a
29	chr12:372139-372189	HEEpiC	esophagus:	n/a
30	chr12:392537-392587	HIPEpiC	eye:	n/a
31	chr12:378771-378821	HEK293	kidney:	embryo
32	chr12:372139-372189	PFSK-1	brain:	n/a
33	chr12:372139-372189	HAEpiC	amniotic membrane:	n/a
34	chr12:372049-372099	Hela-S3	cervix:	n/a
35	chr12:372246-372296	HCM	heart:	n/a
36	chr12:372259-372309	GM06990	blood:	n/a
37	chr12:372139-372189	NHBE	bronchial:	n/a
38	chr12:372790-372840	SK-N-SH_RA	brain:	n/a
39	chr12:372259-372309	AG04449	skin:	fetal
40	chr12:372191-372241	U87	brain:	n/a
41	chr12:372246-372296	NH-A	brain:	n/a
42	chr12:371950-372000	GM12878	blood:	n/a
43	chr12:372139-372189	SAEC	small airway:	n/a
44	chr12:371916-371966	K562	blood:	n/a
45	chr12:372049-372099	PFSK-1	brain:	n/a
46	chr12:372191-372241	Hela-S3	cervix:	n/a
47	chr12:372049-372099	MCF10A-Er-Src	breast:	n/a
48	chr12:372246-372296	HIPEpiC	eye:	n/a
49	chr12:372790-372840	HNPCEpiC	eye:	n/a
50	chr12:392537-392587	K562	blood:	n/a

(count:14 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:391396..394249-chr12:395350..397810,2	K562	blood:
2	chr12:391396..393092-chr12:395064..396850,2	K562	blood:
3	chr12:391396..394249-chr12:395350..397810,2	K562	blood:
4	chr12:391396..393092-chr12:395064..396850,2	K562	blood:
5	chr12:303209..305233-chr12:388816..390804,2	K562	blood:
6	chr12:381899..384416-chr12:386819..388918,2	K562	blood:
7	chr12:371815..374343-chr12:375834..377592,4	K562	blood:
8	chr12:378409..380462-chr12:383368..386178,2	MCF-7	breast:
9	chr12:378409..380462-chr12:383368..386178,2	MCF-7	breast:
10	chr12:381899..385111-chr12:386819..388918,3	K562	blood:
11	chr12:371815..373339-chr12:375834..377443,2	K562	blood:
12	chr12:371632..373367-chr12:383696..385601,2	MCF-7	breast:
13	chr12:381899..384416-chr12:386819..388918,2	K562	blood:
14	chr12:381899..385111-chr12:386819..388918,3	K562	blood:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-KDM5A-2	chr12:367087-367167	NONHSAT025324
2	lnc-KDM5A-1	chr12:383120-386289	ENSG00000261799.1

No data

Variant related genes	Relation type
ENSG00000255746	TF binding region
SLC6A13	TF binding region
ENSG00000261799	TF binding region
ENSG00000255746	CpG island
SLC6A13	CpG island
ENSG00000261799	CpG island
ENSG00000010379	chromatin interactions

Extended variants
information (count: 1181 )
Associated
traits (count: 85 )

Variant overlapped rSNPs/rCNVs (count:1181 , 50 per page) page: 1 2 3 4 5 6 7 ... 24

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs532019506	chr12:366820-366821	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs552547875	chr12:366835-366836	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs3837515	chr12:366886-366887	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs397850085	chr12:366888-366889	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs373445265	chr12:366911-366912	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs376849245	chr12:366926-366927	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs3782856	chr12:366934-366935	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs553425166	chr12:366956-366957	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs533410059	chr12:366964-366965	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs538751160	chr12:367050-367051	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs553786567	chr12:367068-367069	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs182350062	chr12:367082-367083	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs138037043	chr12:367161-367162	Weak transcription Enhancers Flanking Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
14	rs554253149	chr12:367197-367198	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs373177291	chr12:367198-367199	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs376108719	chr12:367254-367255	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs78455784	chr12:367261-367262	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs558338313	chr12:367264-367265	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs150110797	chr12:367365-367366	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs186475587	chr12:367370-367371	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs190932170	chr12:367378-367379	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs560600097	chr12:367393-367394	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs138398033	chr12:367410-367411	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs183918803	chr12:367451-367452	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs551445756	chr12:367469-367470	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs561124429	chr12:367488-367489	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs570150326	chr12:367489-367490	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs550456909	chr12:367498-367499	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs146165749	chr12:367550-367551	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs115783661	chr12:367571-367572	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs567790180	chr12:367576-367577	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs138995121	chr12:367581-367582	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs535946023	chr12:367586-367587	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs76139800	chr12:367607-367608	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs569266402	chr12:367626-367627	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs550046437	chr12:367650-367651	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs6489355	chr12:367709-367710	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs555421457	chr12:367739-367740	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs536948915	chr12:367748-367749	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs142164897	chr12:367758-367759	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs34059463	chr12:367861-367862	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs576642533	chr12:367879-367880	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs520932	chr12:367902-367903	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
44	rs534502424	chr12:367929-367930	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs146352033	chr12:367987-367988	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs553282063	chr12:367991-367992	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs561277262	chr12:368002-368003	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs188464318	chr12:368003-368004	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs112621757	chr12:368040-368041	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs373563197	chr12:368045-368046	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:85)

Disease	PMID	Source
Cancer	20164920	CNVD
Myelofibrosis	22110671	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Glaucoma	21310917	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Malignant peripheral nerve sheath tumor	19844265	CNVD
Squamous cell cancer	19607727	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Mental retardation	17847001	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
abnormal development	18461090	CNVD
Ovarian cancer	20844748	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Medulloblastoma	16968546	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Breast cancer	22032731	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Prostate cancer	21965145	CNVD
Acute myeloid leukemia	16864856	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Disorders of sex development	21048976	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Prostate cancer	19156837	CNVD
Emphysema	19352772	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Malignant germ cell tumour	17285132	CNVD
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
small cell lung cancer	20016488	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21509527	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21785460	CNVD
Autism	22495309	CNVD
Ovarian cancer	21720365	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Glioblastoma multiforme	22291905	CNVD

Chromatin state (count:594 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:363200-370200	Weak transcription	Fetal Kidney	kidney
2	chr12:364200-366800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr12:366000-366800	Enhancers	K562	blood
4	chr12:366600-366800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
5	chr12:366600-367000	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
6	chr12:366600-367600	Flanking Active TSS	HepG2	liver
7	chr12:366600-368000	Enhancers	Liver	Liver
8	chr12:366800-367000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr12:366800-371400	Weak transcription	K562	blood
10	chr12:367000-371200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
11	chr12:367600-368000	Bivalent Enhancer	HepG2	liver
12	chr12:367800-368000	Enhancers	HSMMtube	muscle
13	chr12:368000-371200	Weak transcription	HSMMtube	muscle
14	chr12:370200-371200	Enhancers	Fetal Kidney	kidney
15	chr12:371200-371400	Enhancers	Thymus	Thymus
16	chr12:371200-371600	Enhancers	HSMMtube	muscle
17	chr12:371200-372000	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
18	chr12:371200-372000	Flanking Active TSS	Fetal Kidney	kidney
19	chr12:371200-372400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
20	chr12:371200-372400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
21	chr12:371200-372400	Enhancers	Fetal Muscle Leg	muscle
22	chr12:371200-372400	Enhancers	HepG2	liver
23	chr12:371200-373200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
24	chr12:371400-372200	Weak transcription	Thymus	Thymus
25	chr12:371400-372400	Bivalent Enhancer	Fetal Lung	lung
26	chr12:371400-373400	Enhancers	K562	blood
27	chr12:371600-372000	Enhancers	ES-I3 Cell Line	embryonic stem cell
28	chr12:371600-372000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
29	chr12:371600-372000	Enhancers	iPS-18 Cell Line	embryonic stem cell
30	chr12:371600-372000	Flanking Active TSS	HSMMtube	muscle
31	chr12:371600-372400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
32	chr12:371600-372600	Enhancers	Fetal Heart	heart
33	chr12:371600-373600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
34	chr12:371600-373600	Enhancers	HSMM	muscle
35	chr12:371800-372000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
36	chr12:371800-372200	Enhancers	Breast Myoepithelial Primary Cells	Breast
37	chr12:371800-372400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
38	chr12:371800-372600	Enhancers	Placenta	Placenta
39	chr12:371800-373000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
40	chr12:371800-373400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
41	chr12:371800-373400	Enhancers	NH-A	brain
42	chr12:371800-373600	Weak transcription	Primary T helper naive cells from peripheral blood	blood
43	chr12:371800-376800	Weak transcription	Brain Anterior Caudate	brain
44	chr12:372000-372200	Enhancers	Fetal Kidney	kidney
45	chr12:372000-372400	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
46	chr12:372000-372400	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
47	chr12:372000-372800	Enhancers	HSMMtube	muscle
48	chr12:372000-373400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
49	chr12:372000-376200	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
50	chr12:372000-376400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links